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Abstract 
Silver nanoparticles (AgNPs) are one of the most abundantly used nanomaterials. Following exposure, AgNPs 
can accumulate in various organs including kidneys. This study aimed to determine the effects of increased 
doses of AgNPs on the kidneys of adult male albino mice. Sixty adult white male mice (20-25 g) were 
randomized divided equally into four groups (15 mice each): control group (saline solution), low-dose group 
(LD AgNPs) was intraperitoneal (i.p.) injected with 1 g/ kg, medium dose group (MD AgNPs) was i.p. injected 
with a dose of 2 g/ kg and high dose group (HD AgNPs) was i.p. injected with a dose of 4 g/ kg. Samples were 
taken from each group after one week, two weeks and four weeks of injection. Then blood was collected from 
all animals for serum analysis of kidney functions (serum creatinine, uric acid and blood urea nitrogen) at the 
end of each period and the kidneys were examined microscopically. The results showed impaired kidney 
function as revealed by increased in sera levels of creatinine, uric acid and blood urea nitrogen in rats treated 
with AgNPs. The study of light microscopy showed tissue changes in the kidney membranes including 
programmed death and focal necrosis. One of the most significant effects was changes in nuclei that appeared 
either enlarged or bilateral in the kidney cells. The biochemical and structure were more prominent by increased 
dose and prolonged duration. The study concluded that despite the benefits of silver nanoparticles, it is 
important to test the safety of the use of different doses to determine the safe dose, especially on vital organs 
such as kidneys. 
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1. Introduction 
Silver nanoparticles (AgNPs), also known as nano-silver, have been used into numerous food substances and 
medical applications [1]. AgNPs had strong antimicrobial [2], antifungal [3] and antiviral [4] characteristics. 
However, in despite of their usefulness, increasing evidence suggests the side effects of AgNPs in animals and 
human. Silver nanoparticles are nanoparticles of silver with size range from 1-100 nm. Various shapes of 
nanoparticles can be made depending on application at hand. Commonly used shapes are spherical nanoparticles 
but octagonal, diamond, and thin sheets are also used [5]. 
Researchers showed that the side effects of these nanoparticles are depend on the dose and size. It has been 
reported that AgNPs are toxic than other metal nanoparticles, as aluminum, nickel, iron, and manganese [6]. The 
side effects of free silver ions on humans and animals are permanent skin bluish-gray discoloration (argyria) 
or eyes (argyrosis), liver and kidney damage; eye, skin, respiratory tract, and intestinal tract irritations; and 
untoward changes in blood cells when given through oral, inhalation or subcutaneous routes [7, 8]. 
Different types of AgNPs-induced toxicities have been reported in in vitro and in vivo researches. Earlier in 
vitro studies have reported increased cytotoxicity [9], genotoxicity [9, 10], oxidative stress and mitochondrial 
damage [11] following AgNPs exposure. For the evaluation of nanomaterials, in vitro assays may not reflecting 
in vivo nanomaterials toxicity due to the complex nature of nanomaterials and the complicated processes of 
uptake, deposition and distribution of nanoparticles in the whole body [12]. In vivo studies demonstrated that 
AgNPs enter the blood circulation and accumulate in organs including the liver, brain, kidneys, lungs, spleen 
and testes [6, 8, 13]. Despite their widespread use, there is only limited data on safety, toxicology and exposure 
of silver nanoparticles. 
This experimental study aim to evaluate the potential toxic effect of intraperitoneal injection of different doses 
of silver nanoparticles on the renal ultrastructure and function of male albino mice.  
2. Materials and Methods 
2.1 Chemicals 
Ascorbic acid, silver sulfate, sodium borohydride, tri-sodium phosphate 1-hydrate were obtained from Sigma 
Aldrich, USA. Epoxy resin kit, glutaraldehyde and osmium tetra oxide were purchase from SPI, USA. 
Creatinine, urea nitrogen and uric acid kits were purchase from Siemens Com., Munich, Germany.  
2.2 Silver nanoparticles (AgNPs)  
AgNPs were obtained from Sigma Aldrich, USA (cat. 576832), with particle size of less than 100 nm, 99.5% 
purity and 0.2% PVP as dispersant. Size distribution in the medium (double distilled water), polydispersity, 
agglomeration and charge on these particles were assessed using dynamic light scattering (DLS). AgNPs were 
suspended in double distilled water (DDW) at various concentrations ranging from 5μg/mL to 40 mg /mL, 
sonicated (Vibra- CellTM, Sonics & Materials, Inc. USA) for 10 minute on ice at 4˚C and analyzed by DLS 
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(Zetasizer Nano-ZS, Malvern Instruments, Malvern, UK). The AgNPs were distinguishing by using high 
resolution-transmission electron microscopy (HR-TEM). Silver Nano powders were dissolved in 70% Ethyl 
alcohol solution using a so nicator (BRANSON 1510). The suspended Ag NPs were then mounted on carbon 
coated copper grid. The shape of coated samples was seen by high resolution-transmission electron microscopy 
(HR-TEM; JEM-2100F, Jeol, Tokyo, Japan) instrument operating at an accelerating voltage of 200 KV [14]. 
The particle size shape and surface morphology was confirmed using Transmission electron microscope (TEM). 
2.3 Animals 
Sixty male albino mice of the SWR strain, weighing 22.0 – 25.0 g were used in the present research. The 
experimental animals were purchased from the Experimental Animal Unit of King Fahd Medical Research 
Center, King Abdul-Aziz University, Jeddah, Saudi Arabia. The mice were distributed into four groups (fifteen 
mice per group) and were housed in standard plastic cages at an environmentally controlled (temperature 25oC, 
relative humidity 55%, 12- h light /12- h dark cycles). Standard diet, commercial feed pellets, and tap water 
were freely available. The procedures used in this study are approved by Animal Ethics Committee of King 
Abdul Aziz University. 
2.4 Experimental protocol 
After one week of acclimation, the mice were randomly sorted into 4 equal groups as followings: control (saline 
solution), low-AgNPs (1g/kg), middle- AgNPs (2 g/kg), and high- AgNPs (4 g/kg.). The animals were kept 
fasting for 12 hours before injected. The mice were injected intraperitoneal with one dose of AgNPs. After 
administration; third of the animals were anesthetized and sacrificed on day 7, third on day 14 and third on day 
28 after injection. Before scarification venous blood samples were collected from retro-orbital veins. The kidney 
specimens were rapidly collected from each group and there were kept in 10% formalin for light and 2.5% 
glutaraldehyde for electron microscopic examination [15]. 
2.5 sampling and analysis 
Mice were anaesthetized by using diethyl ether and venous blood samples were collected from retro-orbital 
veins in non-heparinized tube after 1st, 2nd and 4th weeks. The blood was centrifuged at 3000 rpm for 10 min and 
sera were collected and kept at -80 0C. The creatinine method employs a modification of kinetic Jaffe reaction. 
This method reported to be less susceptible than conventional method to interference from non-creatinine, Jaffe-
positive compound [16]. The uric acid method is modification of uricase method that was reported by Bulgar 
and Johns [17], later modified by Kalckar [18]. Measurement of uric acid by estimated the absorbance loss at 
293 nm following uricase treatment is more specific than other indirect methods. Urea is the major nitrogen-
containing metabolic product of protein breakdown in humans. The principal utility of urea nitrogen 
determination lies in conjunction with measurement of creatinine in serum of plasma to discriminate between 
prerenal and postrenal azotemia. Urease specifically hydrolyzes urea to form ammonia and carbon dioxide. The 
ammonia is used by glutamate dehydrogenases enzyme (GLDH) to reductively aminate a-ketoglutarate (a-KG), 
with reduced nicotinamide-adnine dinucleotide (NADH) oxidation. The change in absorbance at 340 nm due to 
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NADH disappearance is directly proportional to urea nitrogen concentration and is measured using a 
biochromatic (340, 383 nm) rate method. 
2.6 Histopathological examination 
At the end of experiments, animals were killed and the kidneys were excised and washed then fixed in 10% 
buffered formal saline (10% formalin with 0.9% NaCl). Samples were dehydrated and embedded in paraffin 
wax. Sections 4-5 μm thick were stained with haematoxylin and eosin (H&E) accordance to Drury and 
Wallington [19] and examined under Olympus trinocular microscope (BX-51). Sample photomicrographs were 
taken primarily under different power of magnification. 
2.7 Statistical analysis 
Statistical analyses were made using SPSS version 20 (SPSS, Chicago, IL). All data was expressed as mean 
and standard deviation (SD). For significance verification by groups in the same week versus control, one-way 
ANOVA was performed, followed by LSD test. For significance verification by weeks in the same group versus 
1st week, paired student “t” test was performed. P value of <0.05 was considered statistically significant.  
3. Results 
3.1 Silver Nanoparticles 
Transmission electron microscopy (TEM) is specific method for imaging nanomaterials to obtain quantitative 
assessment of particles and/or size and shape as shown in Figure (1).  
 
Figure 1: Showed characterization of prepared silver nanoparticles. The TEM micrograph of the aggregation of 
suspended silver nanoparticles in water used for intraperitoneal administration which ranging from 18±5nm in 
diameter. HRTEM image showed the Ag NPs hexagonal in shape 18±5nm diameter. a TEM electron 
micrograph of silver nanoparticles. (Bar = 20 nm). b HRTEM image of Ag nanoparticle hexagonal shape, scale 
bar 2 nm. 
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3.2 Kidney function tests 
Table 1:  Comparison of the effects of intraperitoneal injections of different concentrations of silver 
nanoparticles on serum creatinine levels (umol/L), uric acid (umol/L) and blood urea nitrogen (mmol/L)  in 
adult male albino mice in at various weeks. 
Data are expressed as mean +/- standard deviation. *: significance versus control group using One-way ANOVA 
(LSD) test. +: significance versus 1st week in the same group using paired student “t” test.  
Groups 
1st week 2nd week 4th week 
Mean ± SD P-value Mean ± SD P-value Mean ± SD P-value 
Creatinine levels (umol/L) 
Control 12.00±1.00  12.33±0.58 0.423 12.00±0.00 1.000 
LD Ag-NPs 10.67±0.58 0.050* 9.67±0.58 0.0001
* 
0.225 9.33±0.58 0.001
* 0.184 
MD  Ag-NPs 12.67±0.58 0.282 7.33±0.58 0.0001* 0.004+ 9.67±0.58 0.002
* 
0.035+ 
HD  Ag-NPs 7.67±0.58 0.0001* 10.33±0.58 0.003
*  
0.015+ 11.00±1.00 
0.094 
  0.010+ 
Uric acid level (umol/L) 
Control 110.00±0.00 - 111.00±1.00 0.051 110.33±0.58 0.052 
LD Ag-NPs 201.67±3.51 0.0001* 211.33±0.58 0.0001
*     
0.054 215.67±1.16 
0.0001*     
0.012+ 
MD  Ag-NPs 245.33±4.04 0.0001* 212.67±1.16 0.0001
*     
0.003+ 216.33±1.53 
0.0001*     
0.003+ 
HD  Ag-NPs 437.67±17.16 0.0001* 271.67±3.51 0.0001
*     
0.003+ 318.33±1.53 
0.0001*     
0.007+ 
Blood urea nitrogen (mmol/L) 
Control 7.33±0.58  7.00±0.00 0.423 7.00±1.00 0.742 
LD Ag-NPs 8.33±0.58 0.122 10.33±0.58 0.0001
* 
0.074 10.33±0.58 0.001
* 0.074 
MD  Ag-NPs 9.33±0.58 0.009* 13.67±0.58 0.0001* 0.006+ 14.33±0.58 0.0001
*0.01
3+ 
HD  Ag-NPs 11.00±1.00 0.0001* 17.00±1.00 0.0001
* 
1.000 17.00±1.00 
0.0001* 
1.000 
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The results showed that serum creatinine was significantly lowered in low, medium and high doses treated 
groups at 2nd and 4th tested weeks and in the low and high doses at 1st week versus control groups. Serum 
creatinine levels were significantly decreased in 2nd and 4th weeks in MD AgNPs treated group compared with 
1st week. While, in HD Ag-NPs treated group, serum creatinine levels at 2nd and 4th weeks were significantly 
increased compared with 1st week. Serum level of uric acid (umol/L) after i.p. injection of Ag-NPs was 
significantly higher in LD AgNPs, MD AgNPs and HD AgNPs treated groups in the 1st, 2nd and 4th weeks 
compared with control. In LD AgNPs treated group, uric acid level was significantly increased in 4th compared 
to 1st week. While in MD AgNPs and HD AgNPs treated groups, uric acid levels were significantly decreased in 
the 2nd and 4th weeks after treatment compared with 1st week. At 2nd and 4th week of Ag-NPs administration, 
serum urea nitrogen was significantly increased in low, medium and high dose treated groups while, at the 1st 
week, it was significantly increased in medium and high dose treated groups compared with control. At 2nd and 
4th week of Ag-NPs administration, serum urea nitrogen level was significantly higher in MD Ag-NPs treated 
groups compared with control. 
3.3 Histopathological study of the kidney tubules and Corpuscles 
In the 1st week, renal tubules in the control group showed normal tubules with narrow lumen, cuboidal epithelial 
lining having vesicular nuclei, capillaries around the tubules are non-congested. Renal tubules in LD group 
showed dilated Lumina, low height epithelium and the capillaries around tubules are congested. In the MD 
group, tubular section showed disorganization of tubule shape, dilation of tubule Lumina that contains    some 
protein casts and congested capillaries. In the HD group, tubules showed marked dilation with reticulated 
content (Figure 2). 
 
Figure 2: Sections from mice kidney in first week to show renal tubules of a. control: Normal tubules with 
narrow lumen (white arrow) cuboidal epithelial lining having vesicular nuclei (arrows). Capillaries around the 
tubules are non-congested (black arrow). b. LD: Renal tubules showed dilated lumina and low height epithelium 
(white arrow). Capillaries around tubules are congested (black arrow). c. MD:  Disorganization of tubule shape 
and dilation of tubule lumina (white arrows) some contains   protein casts. Capillary congestion could be seen 
(black arrow). d. HD. Showed marked dilated tubules with reticulated content (white arrow) (H & E stain   x 
400). 
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At the 1st week, the Bowman’s capsule in the control group showed normal renal corpuscle and glomerulus. LD 
AgNPs group showed normal renal corpuscle with normal Bowman capsule and normal glomerulus. While, MD 
AgNPs group showed enlarged renal corpuscle, wide Bowman space, dilated glomerulus capillaries with 
decrease cellularity. HD AgNPs group showed normal renal corpuscle and normal glomerulus (Figure 3). 
 
Figure 3: Sections in cortical regions of mice kidney in First week to show a. control: showing normal renal 
corpuscle (white arrow) and glomerulus (star).  b. L D: Normal renal corpuscle with normal Bowman capsule 
(white arrow) and normal glomerulus (star). c. MD: enlarged renal corpuscle, wide Bowman space (white 
arrow), dilated glomerulus capillaries with decrease cellularity (star). d. HD: normal renal corpuscle (white 
arrow) and normal glomerulus (star) (H&E stain x1000). 
In the 2nd week, microscopic examination of the tubules of the control group showed normal tubules with 
narrow lumen lined with cuboidal epithelial that had vesicular nuclei. The capillaries around the tubules are non-
congested. In the LD group, tubules showed marked dilation with loss of outlines. The lumen contains fine 
reticulated material. Examination of MD group showed loss of tubule outlines, dilated lumen, and presence of 
reticulated materials. HD group showed marked tubule dilation that contains hyaline protein casts (Figure 4). 
 
Figure 4: Sections from mice kidney in Second week to show renal tubules of  a. control: normal tubules with 
narrow lumen (white arrow) cuboidal epithelial lining having vesicular nuclei (arrows). Capillaries around) 
tubules are non-congested (black arrow). b. LD: marked dilation of tubules with loss of outlines. The lumen 
contains fine reticulated material (white arrows). c. MD:  showed similar loss of tubule outline's dilation, some 
contain reticulated materials (arrows). d. HD:  marked tubule dilation and most full of hyaline protein casts 
(white arrows). (H&E stain   x 400) 
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The 2nd week showed that in the control group, normal renal corpuscle and glomerulus. In LD AgNPs group 
showed wide Bowman space and disorganization of glomerulus with capillary dilation. In MD AgNPs group 
showed also irregular Bowman capsule and wide space, glomerular dilation and decrease cellularity. HD AgNPs 
group showed wide capsular space and glomerular congestion (Figure 5). 
 
Figure 5: Sections in cortical regions of mice kidney in second week to show. a. control: showing normal renal 
corpuscle (white arrow) and glomerulus (star). b. LD: showed wide Bowman space (white arrow) and 
disorganization of glomerulus with capillary dilation (star).  c. MD: showed also irregular Bowman capsule and 
wide space (white arrow), glomerular dilation and decrease cellularity (star). d. HD: showing wide capsular 
space (white arrow) and glomerular congestion (star). (H&E stain x1000) 
In the fourth week, renal tubules of control group showed narrow lumina. Tubules in LD group showed 
increased of tubular dilation with presence of casts and marked capillary congestion. Renal tubules of MD group 
showed marked tubular dilation and presence of luminal reticulated material. Most tubules showed dilated 
lumina and presence of protein casts in HD treated group (Figure 6). 
 
Figure 6: Sections from mice kidney in Fourth week to show renal tubules of a. Control: showing normal 
tubules with narrow lumina (white arrows). b. LD: showing increased of tubular dilation (arrows) with presence 
of casts. Marked capillary congestion (black arrows). c. MD: marked tubular dilation and presence of luminal 
reticulated material (white arrow). d. HD:  most tubules showed dilated lumina and presence of protein casts. 
(H&E stain   x 400) 
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The 4th week showed that in control group, normal renal corpuscle and Bowman capsule and normal 
glomerulus. In LD AgNPs group, irregular Bowman capsule with wide space and glomerular capillary 
congestion. In MD AgNPs group, irregular Bowman capsule with wide space and slight capillary congestion. In 
HD AgNPs group, marked decrease in renal corpuscle size with wide Bowman space and glomerular capillary 
congestion (Figure 7). 
 
Figure 7: Sections in cortical regions of mice kidney in Fourth week to show a. control: normal renal corpuscle 
and Bowman capsule (white arrow) and normal glomerulus (star). b. LD: irregular Bowman capsule with wide 
space (white arrow) and glomerular capillary congestion (star). c. MD: irregular Bowman capsule with wide 
space (white arrow) and slight capillary congestion (star).  d. HD: marked decrease in renal corpuscle size with 
wide Bowman space (white arrow) and glomerular capillary congestion (star) (H&E stain x1000). 
4. Discussion  
Silver nanoparticles are widely used in various fields as food, consumer, health care, and industrial purposes, 
due to their specific physical and chemical characters. These had electrical, optical, thermal, electrical 
conductivity and biological properties [20].  Khodadadi and his colleagues [21] stated that the silver 
nanoparticles have high toxicity than other materials. Silver nanoparticles can destruct different 
microorganisms, so, have side effects like many medications as after thet entering the body, they are 
metabolized in liver and excreted by the kidneys, therefore, liver and kidney are affected more than other organs 
[22].  
The properties of silver nanoparticles such as size, shape, surface charge, covering, agglomeration, and 
dissolving rate are important for their biological actions. Smaller particles have larger surface area and, so have 
a greater toxic potential than large particles [23]. The rate of particle dissolution depends on its chemical and 
surface properties as well as on its size and is affected by the surrounding media [24]. This process leads to 
surface oxidation and liberation of cytotoxic silver ions. High resolution transmission electron microscope 
images of Ag-NPs at various magnifications confirmed hexagonal shapes of silver nanoparticles with most 
clearly apparent average size of 18 ± 5 nm. HRTEM micrograph reveals many details at higher magnification 
with clearly observable crystallographic planes of silver. The repeat unit profile for interplanar distance is 
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around 0.24 nm. These results were in agreement with the author [25] who found that the lattice space profile 
Ag NPs is about 0.24nm. After studying the UV-Vis spectrum of silver nanoparticles, shown above, showed a 
hump at nearly 370 nm corresponding to band gap width of 3.35 e. v. which confirm the presence of silver nano 
particles. This band gap value may enhance the performance of silver nanoparticles for kidney toxicity male 
albino mice. These results come in accordance with those of Sastry and his colleagues [26] who found the band 
gap with of silver nanoparticle of 3.35 e. v. 
The results of the present work showed that AgNPs cause alterations in the blood biochemical parameters. 
Blood urea nitrogen is a marker of kidney health. Creatinine is a waste product excreted by the kidneys. It 
accurately assesses the underlying kidney functions as it is less affected by diet type, stress and dehydration. 
Blood urea nitrogen and creatinine are two important factors to assess kidney functions and level of these factors 
in blood serum is increased by kidney destruction [27]. In the current study, it was showed the effects of 
intraperitoneal injections of low, medium and high doses of AgNPs on serum creatinine levels in different 
groups of adult male albino mice at 1st, 2nd and 4th weeks. The results showed that serum creatinine was 
significantly lowered in low, medium and high doses treated groups at 2nd and 4th tested weeks and in the low 
and high dose at 1st week versus control groups. The result of the experimental studies by the author [28] 
demonstrated that Ag-NPs affected the kidney functions in gender-dependent manner so that marked kidney 
toxicity was reported in female mice. This was indicated by a significant decrease of serum creatinine level and 
hyperkalemia in female mice than male. On the other hand, Jarrar and his colleagues [29] found that the 
creatinine blood levels were raised significantly in all mice administered AgNPs in comparison with control 
ones. The results of current work showed that the serum urea nitrogen and uric acid were significantly increased 
in low, medium and high dose treated groups while, at the 1st week, it was significantly increased in medium 
and high dose treated groups than control. These results are accordance with Abdel-Raouf and his colleagues 
[30] who indicated that blood urea nitrogen, uric acid and creatinine activities were significant elevated in 
gentamicin intoxicated rats in comparison to control group. On the contrary, Jarrar and his colleagues [29] 
mentioned nonsignificant elevation of uric acid level in the blood of mice received 10 nm silver particles. 
Heydrnejad and Samani [28] reported that the administration of Ag-NPs to male and female mice produced 
changes in serum levels of blood urea nitrogen and creatinine.  
Many studies revealed that exposure of AgNPs led to clear accumulation in different organs as liver, kidneys, 
testes, lungs, and brain [7, 31, 32]. Previously, the liver and kidneys have been described as main organs for 
silver distribution, whether the exposure was orally [31], intravenously [33], subcutaneously [8] or through 
inhalation [34]. In accordance with the previous results, the present study proved that the histopathological 
findings of the kidney male albino mice after single intraperitoneal administrated with AgNPs through 1st, 2nd 
and 4th weeks were affected male albino mice kidney histology represented by necrosis, cytoplasmic vacuoles, 
dilation and congestion of central vein, In kidney there are some histological changes such as irregular in renal 
corpuscle size, wide Bowman space, dilated glomerulus capillaries with decrease cellularity and glomerular 
capillary congestion. Disorganization of tubule shape and dilation of tubule Lumina some contains protein casts. 
In vivo studies have shown that AgNPs are related to injuries to the brain, liver, and lung [35]. In the kidneys, 
accumulations have been reported to occur in renal glomerular basement membrane [36, 37] and in the 
mesangium [38]. The histological view in treated kidney’s tissue with Ag NPs demonstrated necrosis of 
American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2018) Volume 50, No  1, pp 190-203 
200 
 
glomerular cells, bowman capsule and proximal tubular region with program cell death sequences [39]. Previous 
studies on experimental animals and in vitro have reported that toxicity of silver nanoparticles is related to 
oxidative stress induction [40], apoptosis [40] and induction of lipid peroxidation [41]. The effects of silver 
nanoparticle on the kidney were that the cytoplasm showed some mitochondria with destroyed cristae and 
numerous large membranous vesicles. The glomeruli showed podocytes with swollen and elongated primary 
and secondary processes, and the basement membrane of the endothelial cells in the capillary tufts was 
thickened [42]. Other investigators have reported deposition of ingested silver in the renal tubules and 
glomerular basement membrane [43], as well as mesangial cells proliferation [44]. Further, swelling of renal 
epithelium and presence of membranous vacuoles along with hypertrophied nucleoli had been shown in animals 
treated with AgNPs [45, 46, 47].     
5. Conclusions  
We concluded that the organs mostly affected after intraperitoneal injection of AgNPs were the kidneys. AgNPs 
can induce several morphological and functions alterations of the kidneys that is dose and time dependent that 
leads to destruction of the glomeruli and tubules of the kidneys. Further studies of AgNPs are being conducted 
in mice for a better understanding of the pathway mechanisms underlying those lesions  
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